A New Dawn in Alzheimer's Treatment: Balancing Breakthroughs and Systemic Challenges
Published on: Sept. 23, 2025, 5:04 a.m. | Source: Devdiscourse
Researchers highlight the necessity of integrating healthcare reforms with emerging treatments like lecanemab and donanemab to address Alzheimer’s disease. While these drugs offer potential, they are accompanied by high costs and complex diagnostics. Global coordination and public health action are essential to ensure equitable treatment for all affected individuals.
